Nivolumab-Induced Colitis Treated by Infliximab.
Division of Gastroenterology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Morioka, Japan.
Shunichi
S
Yanai
Division of Gastroenterology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Morioka, Japan.
Shotaro
S
Nakamura
Division of Gastroenterology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Morioka, Japan.
Takayuki
T
Matsumoto
D000074322:Antineoplastic Agents, Immunological / Q000008:administration & dosage / Q000009:adverse effects*; D003092:Colitis / Q000139:chemically induced* / Q000188:drug therapy* / Q000473:pathology; D003113:Colonoscopy; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006651:Histocytochemistry; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D000069285:Infliximab / Q000008:administration & dosage*; D008297:Male; D008853:Microscopy; D008875:Middle Aged; D000077594:Nivolumab / Q000008:administration & dosage / Q000009:adverse effects*; D016896:Treatment Outcome
D000074322:Antineoplastic Agents, Immunological; D005765:Gastrointestinal Agents; D007155:Immunologic Factors; D000077594:Nivolumab; D000069285:Infliximab